miR2Diabetes: A manually curated microRNA database for diabetic microvascular complications miR2Diabetes: A manually curated microRNA database for diabetic microvascular complications miR2Diabetes: A manually curated microRNA database for diabetic microvascular complications

References

# Symbol Disease Subject Sample Reference
1 MIR100 Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
2 MIR101-1 Type 2 Diabetes Mellitus Mouse Serum HIGUCHI, Chigusa, et al. Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes. Metabolism, 2015, 64.4: 489-497. (PMID: 25726255)
3 MIR10A Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
4 MIR10A Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
5 MIR10B Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
6 MIR1179 Diabetic Retinopathy Human patient Serum QING, Shao, et al. Serum miRNA biomarkers serve as a fingerprint for proliferative diabetic retinopathy. Cellular Physiology and Biochemistry, 2014, 34.5: 1733-1740. (PMID: 25427542)
7 MIR1180 Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
8 MIR122 Diabetic Retinopathy Human patient Serum PASTUKH, Nina, et al. Serum miR-122 levels correlate with diabetic retinopathy. Clinical and experimental medicine, 2019, 19.2: 255-260. (PMID: 30673918)
9 MIR122 Diabetic Retinopathy Human patient Serum PASTUKH, Nina, et al. Serum miR-122 levels correlate with diabetic retinopathy. Clinical and experimental medicine, 2019, 19.2: 255-260. (PMID: 30673918)
10 MIR122 End-stage renal disease Human patient Serum REGMI, Anita, et al. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis. Medical science monitor: international medical journal of experimental and clinical research, 2019, 25: 1699. (PMID: 30835718)
11 MIR122 End-stage renal disease Human patient Serum REGMI, Anita, et al. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis. Medical science monitor: international medical journal of experimental and clinical research, 2019, 25: 1699. (PMID: 30835718)
12 MIR1224 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
13 MIR1227 Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
14 MIR1234 Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
15 MIR124-1 Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
16 MIR124-1 Diabetic Nephropathy Rat Renal cortex LI, Dong, et al. Curcumin ameliorates podocytic adhesive capacity damage under mechanical stress by inhibiting miR-124 expression. Kidney and Blood Pressure Research, 2013, 38.1: 61-71. (PMID: 24556741)
17 MIR124-1 Diabetic Nephropathy Rat Renal cortex LI, Dong, et al. MiR-124 is related to podocytic adhesive capacity damage in STZ-induced uninephrectomized diabetic rats. Kidney and Blood Pressure Research, 2013, 37.4-5: 422-431. (PMID: 24247359)
18 MIR124-1 Diabetic Nephropathy Human cell line Podocytes LI, Dong, et al. Curcumin ameliorates podocytic adhesive capacity damage under mechanical stress by inhibiting miR-124 expression. Kidney and Blood Pressure Research, 2013, 38.1: 61-71. (PMID: 24556741)
19 MIR1247 Microalbuminuria Human patient Urine ARGYROPOULOS, Christos, et al. Urinary MicroRNA profiling predicts the development of microalbuminuria in patients with Type 1 diabetes. Journal of clinical medicine, 2015, 4.7: 1498-1517. (PMID: 26239688)
20 MIR125B1 Hyperglycemia Human cell line Umbilical vein endothelial cell (UVEC) SILAMBARASAN, Maskomani, et al. MicroRNAs in hyperglycemia induced endothelial cell dysfunction. International journal of molecular sciences, 2016, 17.4: 518. (PMID: 27070575)
21 MIR126 Diabetic Retinopathy Rat Retina WANG, Yang; YAN, Hua. MicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy. Scientific reports, 2016, 6: 26909. (PMID: 27225425)
22 MIR126 Impaired glucose tolerance Human cell line Mesangial cell CAO, Dong-wei, et al. Upregulation of MiR-126 Delays the Senescence of Human Glomerular Mesangial Cells Induced by High Glucose via Telomere-p53-p21-Rb Signaling Pathway. Current medical science, 2018, 38.5: 758-764. (PMID: 30341510)
23 MIR126 Type 1 Diabetes Mellitus Human patient Urine OSIPOVA, Julia, et al. Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. The Journal of Clinical Endocrinology & Metabolism, 2014, 99.9: E1661-E1665. (PMID: 24937532)
24 MIR126 Diabetic Nephropathy Human patient Plasma BIJKERK, R., et al. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation. American Journal of Transplantation, 2015, 15.4: 1081-1090. (PMID: 25716422)
25 MIR126 Microvascular complications Human patient Serum BARUTTA, Federica, et al. MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study. Acta diabetologica, 2017, 54.2: 133-139. (PMID: 27696070)
26 MIR126 Type 2 Diabetes Mellitus Human patient Serum REZK, Noha A.; SABBAH, Norhan A.; SAAD, Mohamed SS. Role of microRNA 126 in screening, diagnosis, and prognosis of diabetic patients in Egypt. IUBMB life, 2016, 68.6: 452-458. (PMID: 27118517)
27 MIR126 Diabetic Retinopathy Biopsied tissue Endothelial progenitor cell (EPC) DE LA TORRE, Nuria García, et al. Expression of Angiogenic MicroRNAs in Endothelial Progenitor Cells From Type 1 Diabetic Patients With and Without Diabetic RetinopathyMicroRNA Expression in EPCs From DM1 Patients. Investigative ophthalmology & visual science, 2015, 56.6: 4090-4098. (PMID: 26114486)
28 MIR129-1 Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
29 MIR1303 Microvascular complications Human patient Serum WANG, Cheng, et al. Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus. Scientific reports, 2016, 6. (PMID: 26831044)
30 MIR130A Diabetic Nephropathy Human patient Urine BARUTTA, Federica, et al. Urinary exosomal microRNAs in incipient diabetic nephropathy. PloS one, 2013, 8.11: e73798. (PMID: 24223694)
31 MIR130B Hyperglycemia Human cell line Umbilical vein endothelial cell (UVEC) SILAMBARASAN, Maskomani, et al. MicroRNAs in hyperglycemia induced endothelial cell dysfunction. International journal of molecular sciences, 2016, 17.4: 518. (PMID: 27070575)
32 MIR130B Diabetic Nephropathy Human patient Plasma BIJKERK, R., et al. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation. American Journal of Transplantation, 2015, 15.4: 1081-1090. (PMID: 25716422)
33 MIR130B Diabetic Nephropathy Human patient Serum LV, Chuan, et al. The changes in miR‐130b levels in human serum and the correlation with the severity of diabetic nephropathy. Diabetes/metabolism research and reviews, 2015, 31.7: 717-724. (PMID: 25952368)
34 MIR130B End-stage renal disease Human patient Serum MOTAWI, Tarek Kamal, et al. Potential serum biomarkers for early detection of diabetic nephropathy. diabetes research and clinical practice, 2018, 136: 150-158. (PMID: 29253627)
35 MIR130B End-stage renal disease Human patient Serum MOTAWI, Tarek Kamal, et al. Potential serum biomarkers for early detection of diabetic nephropathy. diabetes research and clinical practice, 2018, 136: 150-158. (PMID: 29253627)
36 MIR132 Diabetic Nephropathy Human patient Plasma BIJKERK, R., et al. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation. American Journal of Transplantation, 2015, 15.4: 1081-1090. (PMID: 25716422)
37 MIR133B End-stage renal disease Human patient Animal XIE, Yijun, et al. Urinary exosomal microRNA profiling in incipient type 2 diabetic kidney disease. Journal of diabetes research, 2017, 2017. (PMID: 29038788)
38 MIR135A1 Diabetic Nephropathy Human patient Kidney tissue HE, Feng, et al. MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia, 2014, 57.8: 1726-1736. (PMID: 24908566)
39 MIR135A1 Diabetic Nephropathy Human patient Serum HE, Feng, et al. MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia, 2014, 57.8: 1726-1736. (PMID: 24908566)
40 MIR135B Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
41 MIR140 Hyperglycemia Human cell line Umbilical vein endothelial cell (UVEC) SILAMBARASAN, Maskomani, et al. MicroRNAs in hyperglycemia induced endothelial cell dysfunction. International journal of molecular sciences, 2016, 17.4: 518. (PMID: 27070575)
42 MIR141 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
43 MIR144 Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
44 MIR145 Impaired glucose tolerance Human cell line Retina microvascular endothelial cell (RMEC) HUI, Ying; YIN, Yan. MicroRNA-145 attenuates high glucose-induced oxidative stress and inflammation in retinal endothelial cells through regulating TLR4/NF-κB signaling. Life sciences, 2018, 207: 212-218. (PMID: 29883722)
45 MIR145 Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
46 MIR145 Diabetic Nephropathy Mouse Renal glomerular capsule BARUTTA, Federica, et al. Urinary exosomal microRNAs in incipient diabetic nephropathy. PloS one, 2013, 8.11: e73798. (PMID: 24223694)
47 MIR145 Diabetic Nephropathy Mouse Mesangial cell BARUTTA, Federica, et al. Urinary exosomal microRNAs in incipient diabetic nephropathy. PloS one, 2013, 8.11: e73798. (PMID: 24223694)
48 MIR145 Diabetic Nephropathy Mouse Mesangial cells-derived exosomes BARUTTA, Federica, et al. Urinary exosomal microRNAs in incipient diabetic nephropathy. PloS one, 2013, 8.11: e73798. (PMID: 24223694)
49 MIR145 Diabetic Nephropathy Human patient Urine BARUTTA, Federica, et al. Urinary exosomal microRNAs in incipient diabetic nephropathy. PloS one, 2013, 8.11: e73798. (PMID: 24223694)
50 MIR145 Diabetic Nephropathy Mouse Urine BARUTTA, Federica, et al. Urinary exosomal microRNAs in incipient diabetic nephropathy. PloS one, 2013, 8.11: e73798. (PMID: 24223694)
51 MIR146A Hyperglycemia Rat Heart ABBAS, Bandar. MicroRNA-146a and its adapter proteins are affected by diabetes in rat’s heart. 2016. (PMID: 26925748)
52 MIR146A Hyperglycemia Human cell line Umbilical vein endothelial cell (UVEC) ABBAS, Bandar. MicroRNA-146a and its adapter proteins are affected by diabetes in rat’s heart. 2016. (PMID: 26925748)
53 MIR146A Diabetic Nephropathy Human cell line Retina microvascular endothelial cell (RMEC) HUANG, Youqun, et al. Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. BMC nephrology, 2014, 15.1: 142. (PMID: 25182190)
54 MIR146A Diabetic Nephropathy Rat Kidney tissue ALIPOUR, Mohammad Reza, et al. Upregulation of microRNA-146a was not accompanied by downregulation of pro-inflammatory markers in diabetic kidney. Molecular biology reports, 2013, 40.11: 6477-6483. (PMID: 24057185)
55 MIR146A Diabetic Nephropathy Rat Kidney tissue HUANG, Youqun, et al. Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. BMC nephrology, 2014, 15.1: 142. (PMID: 25182190)
56 MIR146A Diabetic Nephropathy Biopsied tissue Kidney tissue HUANG, Youqun, et al. Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. BMC nephrology, 2014, 15.1: 142. (PMID: 25182190)
57 MIR146A Diabetic Neuropathy Rat Spinal ganglion JIA, Longfei, et al. MicroRNA 146a locally mediates distal axonal growth of dorsal root ganglia neurons under high glucose and sildenafil conditions. Neuroscience, 2016, 329: 43-53. (PMID: 27167084)
58 MIR146A Diabetic Nephropathy Rat Sciatic nerve YOUSEFZADEH, Nasibeh; ALIPOUR, Mohammad Reza; SOUFI, Farhad Ghadiri. Deregulation of NF-кB-miR-146a negative feedback loop may be involved in the pathogenesis of diabetic neuropathy. Journal of physiology and biochemistry, 2015, 71.1: 51-58. (PMID: 25567745)
59 MIR150 Diabetic Retinopathy Human patient Tissue, cell types, and enzyme sources MAZZEO, Aurora, et al. Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects. Experimental eye research, 2018, 176: 69-77. (PMID: 30008390)
60 MIR150 Diabetic Retinopathy Human patient Tissue, cell types, and enzyme sources MAZZEO, Aurora, et al. Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects. Experimental eye research, 2018, 176: 69-77. (PMID: 30008390)
61 MIR150 End-stage renal disease Human patient Animal XIE, Yijun, et al. Urinary exosomal microRNA profiling in incipient type 2 diabetic kidney disease. Journal of diabetes research, 2017, 2017. (PMID: 29038788)
62 MIR150 Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
63 MIR152 Diabetic Nephropathy Human patient Plasma BIJKERK, R., et al. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation. American Journal of Transplantation, 2015, 15.4: 1081-1090. (PMID: 25716422)
64 MIR155 Diabetic Nephropathy Human cell line Retina microvascular endothelial cell (RMEC) HUANG, Youqun, et al. Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. BMC nephrology, 2014, 15.1: 142. (PMID: 25182190)
65 MIR155 Diabetic Nephropathy Rat Kidney tissue HUANG, Youqun, et al. Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. BMC nephrology, 2014, 15.1: 142. (PMID: 25182190)
66 MIR155 Diabetic Nephropathy Biopsied tissue Kidney tissue HUANG, Youqun, et al. Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. BMC nephrology, 2014, 15.1: 142. (PMID: 25182190)
67 MIR155 Diabetic Nephropathy Mouse Podocytes LIN, Xu, et al. MicroRNA-155 deficiency promotes nephrin acetylation and attenuates renal damage in hyperglycemia-induced nephropathy. Inflammation, 2015, 38.2: 546-554. (PMID: 24969676)
68 MIR155 Diabetic Nephropathy Human patient Urine BARUTTA, Federica, et al. Urinary exosomal microRNAs in incipient diabetic nephropathy. PloS one, 2013, 8.11: e73798. (PMID: 24223694)
69 MIR155 Diabetic Retinopathy Human patient Peripheral blood YANG, T. T., et al. Regulatory T cells in the pathogenesis of type 2 diabetes mellitus retinopathy by miR-155. Eur Rev Med Pharmacol Sci, 2015, 19.11: 2010-2015. (PMID: 26125263)
70 MIR15A End-stage renal disease Human patient Animal XIE, Yijun, et al. Urinary exosomal microRNA profiling in incipient type 2 diabetic kidney disease. Journal of diabetes research, 2017, 2017. (PMID: 29038788)
71 MIR15A Diabetic Retinopathy Human patient Vitreous humor HIROTA, Kazunari, et al. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2015, 253.3: 335-342. (PMID: 24970617)
72 MIR15A Diabetic Retinopathy Human patient Blood HIROTA, Kazunari, et al. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2015, 253.3: 335-342. (PMID: 24970617)
73 MIR15A Diabetic Retinopathy Human patient Plasma KAMALDEN, Tengku Ain, et al. Exosomal microRNA-15a transfer from the pancreas augments diabetic complications by inducing oxidative stress. Antioxidants & redox signaling, 2017, 27.13: 913-930. (PMID: 28173719)
74 MIR15A Diabetic Retinopathy Human patient Plasma KAMALDEN, Tengku Ain, et al. Exosomal microRNA-15a transfer from the pancreas augments diabetic complications by inducing oxidative stress. Antioxidants & redox signaling, 2017, 27.13: 913-930. (PMID: 28173719)
75 MIR16-1 Diabetic Nephropathy Rat Urine MOHAN, Aradhana, et al. Urinary exosomal microRNA-451-5p is a potential early biomarker of diabetic nephropathy in rats. PloS one, 2016, 11.4: e0154055. (PMID: 27101382)
76 MIR16-1 End-stage renal disease Human patient Serum ASSMANN, Taís S., et al. Circulating miRNAs in diabetic kidney disease: case–control study and in silico analyses. Acta diabetologica, 2019, 56.1: 55-65. (PMID: 30167868)
77 MIR16-1 End-stage renal disease Human patient Serum ASSMANN, Taís S., et al. Circulating miRNAs in diabetic kidney disease: case–control study and in silico analyses. Acta diabetologica, 2019, 56.1: 55-65. (PMID: 30167868)
78 MIR181A2 Diabetic Nephropathy Human patient Plasma BIJKERK, R., et al. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation. American Journal of Transplantation, 2015, 15.4: 1081-1090. (PMID: 25716422)
79 MIR181C Diabetic Retinopathy Human patient Serum QING, Shao, et al. Serum miRNA biomarkers serve as a fingerprint for proliferative diabetic retinopathy. Cellular Physiology and Biochemistry, 2014, 34.5: 1733-1740. (PMID: 25427542)
80 MIR182 Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
81 MIR183 Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
82 MIR186 End-stage renal disease Human patient Animal XIE, Yijun, et al. Urinary exosomal microRNA profiling in incipient type 2 diabetic kidney disease. Journal of diabetes research, 2017, 2017. (PMID: 29038788)
83 MIR188 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
84 MIR18B Type 1 Diabetes Mellitus Human patient Serum LIU, He-Nan, et al. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1. Biochemical and biophysical research communications, 2018, 505.4: 1236-1243. (PMID: 30333091)
85 MIR18B Type 1 Diabetes Mellitus Human patient Serum LIU, He-Nan, et al. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1. Biochemical and biophysical research communications, 2018, 505.4: 1236-1243. (PMID: 30333091)
86 MIR18B Type 1 Diabetes Mellitus Human patient Serum LIU, He-Nan, et al. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1. Biochemical and biophysical research communications, 2018, 505.4: 1236-1243. (PMID: 30333091)
87 MIR190B Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
88 MIR1912 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
89 MIR1913 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
90 MIR1915 Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
91 MIR1915 Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
92 MIR1915 Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
93 MIR192 Hyperglycemia Human cell line Umbilical vein endothelial cell (UVEC) SILAMBARASAN, Maskomani, et al. MicroRNAs in hyperglycemia induced endothelial cell dysfunction. International journal of molecular sciences, 2016, 17.4: 518. (PMID: 27070575)
94 MIR192 End-stage renal disease Human patient Blood AL‑KAFAJI, Ghada; AL‑MUHTARESH, Haifa Abdulla. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. Molecular medicine reports, 2018, 18.1: 1171-1180. (PMID: 29845236)
95 MIR192 End-stage renal disease Human patient Blood AL‑KAFAJI, Ghada; AL‑MUHTARESH, Haifa Abdulla. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. Molecular medicine reports, 2018, 18.1: 1171-1180. (PMID: 29845236)
96 MIR192 End-stage renal disease Human patient Blood AL‑KAFAJI, Ghada; AL‑MUHTARESH, Haifa Abdulla. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. Molecular medicine reports, 2018, 18.1: 1171-1180. (PMID: 29845236)
97 MIR192 End-stage renal disease Human patient Blood AL‑KAFAJI, Ghada; AL‑MUHTARESH, Haifa Abdulla. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. Molecular medicine reports, 2018, 18.1: 1171-1180. (PMID: 29845236)
98 MIR192 End-stage renal disease Human patient Blood AL‑KAFAJI, Ghada; AL‑MUHTARESH, Haifa Abdulla. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. Molecular medicine reports, 2018, 18.1: 1171-1180. (PMID: 29845236)
99 MIR192 Diabetic Nephropathy Human patient Serum CHIEN, Hung-Yu, et al. Differential microRNA profiles predict diabetic nephropathy progression in Taiwan. International journal of medical sciences, 2016, 13.6: 457. (PMID: 27279796)
100 MIR195 Diabetic Retinopathy Rat Retina MORTUZA, Rokhsana; FENG, Biao; CHAKRABARTI, Subrata. miR-195 regulates SIRT1-mediated changes in diabetic retinopathy. Diabetologia, 2014, 57.5: 1037-1046. (PMID: 24570140)
101 MIR195 Diabetic Retinopathy Human cell line Retina microvascular endothelial cell (RMEC) MORTUZA, Rokhsana; FENG, Biao; CHAKRABARTI, Subrata. miR-195 regulates SIRT1-mediated changes in diabetic retinopathy. Diabetologia, 2014, 57.5: 1037-1046. (PMID: 24570140)
102 MIR199A1 Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
103 MIR199A1 Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
104 MIR199A1 Diabetic Nephropathy Biopsied tissue Kidney tissue YANG, Ruhao, et al. p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO. Scientific reports, 2017, 7: 43409. (PMID: 28240316)
105 MIR19B1 Type 1 Diabetes Mellitus Human patient Serum LIU, He-Nan, et al. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1. Biochemical and biophysical research communications, 2018, 505.4: 1236-1243. (PMID: 30333091)
106 MIR19B1 Type 1 Diabetes Mellitus Human patient Serum LIU, He-Nan, et al. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1. Biochemical and biophysical research communications, 2018, 505.4: 1236-1243. (PMID: 30333091)
107 MIR19B1 Type 1 Diabetes Mellitus Human patient Serum LIU, He-Nan, et al. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1. Biochemical and biophysical research communications, 2018, 505.4: 1236-1243. (PMID: 30333091)
108 MIR200A Hepatic insulin resistance Rat Liver cell line GUO, W., et al. miR-200a regulates Rheb-mediated amelioration of insulin resistance after duodenal–jejunal bypass. International Journal of Obesity, 2016, 40.8: 1222-1232. (PMID: 27121251)
109 MIR200B Diabetic Retinopathy Biopsied tissue Vitreous humor GOMAA, Amir Ramadan; ELSAYED, Eman Tayae; MOFTAH, Reham Fadl. MicroRNA-200b expression in the vitreous humor of patients with proliferative diabetic retinopathy. Ophthalmic research, 2017, 58.3: 168-175. (PMID: 28571008)
110 MIR200B Diabetic Retinopathy Rat Retina MCARTHUR, Kara, et al. MicroRNA-200b regulates vascular endothelial growth factor–mediated alterations in diabetic retinopathy. Diabetes, 2011, 60.4: 1314-1323. (PMID: 21357793)
111 MIR200B Diabetic Retinopathy Mouse Retina MURRAY, Anne R., et al. MicroRNA-200b Downregulates Oxidation Resistance 1 (Oxr1) Expression in the Retina of Type 1 Diabetes Model Oxr1 Expression in Type 1 Diabetes Model. Investigative ophthalmology & visual science, 2013, 54.3: 1689-1697. (PMID: 23404117)
112 MIR200B Diabetic Retinopathy Mouse Retina RUIZ, Michael Anthony; FENG, Biao; CHAKRABARTI, Subrata. Polycomb repressive complex 2 regulates MiR-200b in retinal endothelial cells: potential relevance in diabetic retinopathy. PloS one, 2015, 10.4: e0123987. (PMID: 25884496)
113 MIR200B Diabetic Retinopathy Human cell line Retina microvascular endothelial cell (RMEC) JIANG, Q., et al. Effect of MiR-200b on retinal endothelial cell function in high-glucose condition and the mechanism. Nan fang yi ke da xue xue bao= Journal of Southern Medical University, 2016, 36.4: 577-581. (PMID: 27113191)
114 MIR200B Diabetic Retinopathy Human cell line Retina microvascular endothelial cell (RMEC) JIANG, Qun, et al. Effect of miR-200b on retinal endothelial cell function under high glucose environment. International journal of clinical and experimental pathology, 2015, 8.9: 10482. (PMID: 26617758)
115 MIR200B Diabetic Retinopathy Rat Retina microvascular endothelial cell (RMEC) MCARTHUR, Kara, et al. MicroRNA-200b regulates vascular endothelial growth factor–mediated alterations in diabetic retinopathy. Diabetes, 2011, 60.4: 1314-1323. (PMID: 21357793)
116 MIR200B Diabetic Retinopathy Human cell line Retina microvascular endothelial cell (RMEC) RUIZ, Michael Anthony; FENG, Biao; CHAKRABARTI, Subrata. Polycomb repressive complex 2 regulates MiR-200b in retinal endothelial cells: potential relevance in diabetic retinopathy. PloS one, 2015, 10.4: e0123987. (PMID: 25884496)
117 MIR200B Diabetic Retinopathy Human patient Serum LI, En-Hui, et al. Effects of miRNA-200b on the development of diabetic retinopathy by targeting VEGFA gene. Bioscience reports, 2017, 37.2: BSR20160572. (PMID: 28122882)
118 MIR204 Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
119 MIR20A End-stage renal disease Human patient Serum REGMI, Anita, et al. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis. Medical science monitor: international medical journal of experimental and clinical research, 2019, 25: 1699. (PMID: 30835718)
120 MIR20A End-stage renal disease Human patient Serum REGMI, Anita, et al. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis. Medical science monitor: international medical journal of experimental and clinical research, 2019, 25: 1699. (PMID: 30835718)
121 MIR21 Diabetic Retinopathy Human patient Tissue, cell types, and enzyme sources MAZZEO, Aurora, et al. Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects. Experimental eye research, 2018, 176: 69-77. (PMID: 30008390)
122 MIR21 Diabetic Retinopathy Human patient Tissue, cell types, and enzyme sources MAZZEO, Aurora, et al. Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects. Experimental eye research, 2018, 176: 69-77. (PMID: 30008390)
123 MIR21 Diabetic Nephropathy Mouse Kidney tissue FIORENTINO, Loredana, et al. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta diabetologica, 2013, 50.6: 965-969. (PMID: 23797704)
124 MIR21 Diabetic Nephropathy Biopsied tissue Kidney tissue FIORENTINO, Loredana, et al. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta diabetologica, 2013, 50.6: 965-969. (PMID: 23797704)
125 MIR21 Diabetic Nephropathy Human cell line Mesangial cell FIORENTINO, Loredana, et al. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta diabetologica, 2013, 50.6: 965-969. (PMID: 23797704)
126 MIR21 Diabetic Nephropathy Mouse Mesangial cell ZHANG, Zheng, et al. MicroRNA‐21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS letters, 2009, 583.12. (PMID: 19450585)
127 MIR21 Diabetic Nephropathy Human cell line Mesangial cell ZHANG, Zheng, et al. MicroRNA‐21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS letters, 2009, 583.12. (PMID: 19450585)
128 MIR21 Type 1 Diabetes Mellitus Human patient Urine OSIPOVA, Julia, et al. Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. The Journal of Clinical Endocrinology & Metabolism, 2014, 99.9: E1661-E1665. (PMID: 24937532)
129 MIR21 Diabetic Retinopathy Human patient Plasma JIANG, Qi, et al. Plasma miR-21 expression: an indicator for the severity of Type 2 diabetes with diabetic retinopathy. Bioscience reports, 2017, 37.2: BSR20160589. (PMID: 28108673)
130 MIR21 Diabetic Retinopathy Human patient Plasma JIANG, Qi, et al. Plasma miR-21 expression: an indicator for the severity of Type 2 diabetes with diabetic retinopathy. Bioscience reports, 2017, 37.2: BSR20160589. (PMID: 28108673)
131 MIR21 Diabetic Retinopathy Human patient Plasma JIANG, Qi, et al. Plasma miR-21 expression: an indicator for the severity of Type 2 diabetes with diabetic retinopathy. Bioscience reports, 2017, 37.2: BSR20160589. (PMID: 28108673)
132 MIR21 Type 1 Diabetes Mellitus Human patient Plasma OSIPOVA, Julia, et al. Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. The Journal of Clinical Endocrinology & Metabolism, 2014, 99.9: E1661-E1665. (PMID: 24937532)
133 MIR21 End-stage renal disease Human patient Plasma PEZZOLESI, Marcus G., et al. Circulating TGF-β1–regulated miRNAs and the risk of rapid progression to ESRD in type 1 diabetes. Diabetes, 2015, 64.9: 3285-3293. (PMID: 25931475)
134 MIR21 Atherosclerosis Human patient Plasma ZHANG, Jing-Yun, et al. Circulating MiRNA biomarkers serve as a fingerprint for diabetic atherosclerosis. American journal of translational research, 2016, 8.6: 2650. (PMID: 27398148)
135 MIR21 End-stage renal disease Human patient Serum ASSMANN, Taís S., et al. Circulating miRNAs in diabetic kidney disease: case–control study and in silico analyses. Acta diabetologica, 2019, 56.1: 55-65. (PMID: 30167868)
136 MIR21 Diabetic Nephropathy Human patient Serum CHIEN, Hung-Yu, et al. Differential microRNA profiles predict diabetic nephropathy progression in Taiwan. International journal of medical sciences, 2016, 13.6: 457. (PMID: 27279796)
137 MIR21 Diabetic Retinopathy Human patient Serum QING, Shao, et al. Serum miRNA biomarkers serve as a fingerprint for proliferative diabetic retinopathy. Cellular Physiology and Biochemistry, 2014, 34.5: 1733-1740. (PMID: 25427542)
138 MIR210 Type 1 Diabetes Mellitus Human patient Urine OSIPOVA, Julia, et al. Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. The Journal of Clinical Endocrinology & Metabolism, 2014, 99.9: E1661-E1665. (PMID: 24937532)
139 MIR210 Type 1 Diabetes Mellitus Human patient Plasma OSIPOVA, Julia, et al. Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. The Journal of Clinical Endocrinology & Metabolism, 2014, 99.9: E1661-E1665. (PMID: 24937532)
140 MIR211 Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
141 MIR211 Atherosclerosis Human patient Plasma ZHANG, Jing-Yun, et al. Circulating MiRNA biomarkers serve as a fingerprint for diabetic atherosclerosis. American journal of translational research, 2016, 8.6: 2650. (PMID: 27398148)
142 MIR211 Type 1 Diabetes Mellitus Human patient Serum LIU, He-Nan, et al. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1. Biochemical and biophysical research communications, 2018, 505.4: 1236-1243. (PMID: 30333091)
143 MIR211 Type 1 Diabetes Mellitus Human patient Serum LIU, He-Nan, et al. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1. Biochemical and biophysical research communications, 2018, 505.4: 1236-1243. (PMID: 30333091)
144 MIR211 Type 1 Diabetes Mellitus Human patient Serum LIU, He-Nan, et al. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1. Biochemical and biophysical research communications, 2018, 505.4: 1236-1243. (PMID: 30333091)
145 MIR214 Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
146 MIR214 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
147 MIR216A End-stage renal disease Human patient Urine EL-SAMAHY, Mona Hussein, et al. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes. Journal of Diabetes and its Complications, 2018, 32.2: 185-192. (PMID: 29175120)
148 MIR216A End-stage renal disease Human patient Urine EL-SAMAHY, Mona Hussein, et al. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes. Journal of Diabetes and its Complications, 2018, 32.2: 185-192. (PMID: 29175120)
149 MIR217 Diabetic Nephropathy Mouse Kidney tissue FIORENTINO, Loredana, et al. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta diabetologica, 2013, 50.6: 965-969. (PMID: 23797704)
150 MIR217 Diabetic Nephropathy Biopsied tissue Renal tissue LI, Jing, et al. miR-217 is a useful diagnostic biomarker and regulates human podocyte cells apoptosis via targeting tnfsf11 in membranous nephropathy. BioMed research international, 2017, 2017. (PMID: 29214160)
151 MIR217 Diabetic Nephropathy Human cell line Mesangial cell FIORENTINO, Loredana, et al. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta diabetologica, 2013, 50.6: 965-969. (PMID: 23797704)
152 MIR217 Diabetic Nephropathy Human patient Plasma LI, Jing, et al. miR-217 is a useful diagnostic biomarker and regulates human podocyte cells apoptosis via targeting tnfsf11 in membranous nephropathy. BioMed research international, 2017, 2017. (PMID: 29214160)
153 MIR217 End-stage renal disease Human patient Serum SHAO, Ying, et al. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease. Endocrine, 2017, 55.1: 130-138. (PMID: 27522360)
154 MIR217 End-stage renal disease Human patient Serum SHAO, Ying, et al. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease. Endocrine, 2017, 55.1: 130-138. (PMID: 27522360)
155 MIR217 End-stage renal disease Human patient Serum SHAO, Ying, et al. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease. Endocrine, 2017, 55.1: 130-138. (PMID: 27522360)
156 MIR218-1 Atherosclerosis Human patient Plasma ZHANG, Jing-Yun, et al. Circulating MiRNA biomarkers serve as a fingerprint for diabetic atherosclerosis. American journal of translational research, 2016, 8.6: 2650. (PMID: 27398148)
157 MIR219A2 Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
158 MIR221 Hyperglycemia Human cell line Umbilical vein endothelial cell (UVEC) SILAMBARASAN, Maskomani, et al. MicroRNAs in hyperglycemia induced endothelial cell dysfunction. International journal of molecular sciences, 2016, 17.4: 518. (PMID: 27070575)
159 MIR221 Diabetic Nephropathy Mouse Kidney tissue FIORENTINO, Loredana, et al. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta diabetologica, 2013, 50.6: 965-969. (PMID: 23797704)
160 MIR221 Diabetic Nephropathy Human cell line Mesangial cell FIORENTINO, Loredana, et al. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta diabetologica, 2013, 50.6: 965-969. (PMID: 23797704)
161 MIR221 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
162 MIR221 Diabetic Retinopathy Biopsied tissue Endothelial progenitor cell (EPC) DE LA TORRE, Nuria García, et al. Expression of Angiogenic MicroRNAs in Endothelial Progenitor Cells From Type 1 Diabetic Patients With and Without Diabetic RetinopathyMicroRNA Expression in EPCs From DM1 Patients. Investigative ophthalmology & visual science, 2015, 56.6: 4090-4098. (PMID: 26114486)
163 MIR223 Diabetic Nephropathy Human patient Plasma BIJKERK, R., et al. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation. American Journal of Transplantation, 2015, 15.4: 1081-1090. (PMID: 25716422)
164 MIR23A Type 1 Diabetes Mellitus Human patient Serum LIU, He-Nan, et al. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1. Biochemical and biophysical research communications, 2018, 505.4: 1236-1243. (PMID: 30333091)
165 MIR23A Type 1 Diabetes Mellitus Human patient Serum LIU, He-Nan, et al. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1. Biochemical and biophysical research communications, 2018, 505.4: 1236-1243. (PMID: 30333091)
166 MIR23A End-stage renal disease Human patient Serum REGMI, Anita, et al. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis. Medical science monitor: international medical journal of experimental and clinical research, 2019, 25: 1699. (PMID: 30835718)
167 MIR23A End-stage renal disease Human patient Serum REGMI, Anita, et al. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis. Medical science monitor: international medical journal of experimental and clinical research, 2019, 25: 1699. (PMID: 30835718)
168 MIR23A End-stage renal disease Human patient Serum REGMI, Anita, et al. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis. Medical science monitor: international medical journal of experimental and clinical research, 2019, 25: 1699. (PMID: 30835718)
169 MIR23B Diabetic Nephropathy Mouse Kidney tissue LIU, Haifeng, et al. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy. The international journal of biochemistry & cell biology, 2016, 70: 149-160. (PMID: 26646104)
170 MIR23B Diabetic Nephropathy Mouse Kidney tissue ZHAO, Binghai, et al. MicroRNA-23b targets ras GTPase-activating protein SH3 domain-binding protein 2 to alleviate fibrosis and albuminuria in diabetic nephropathy. Journal of the American Society of Nephrology, 2016, ASN. 2015030300. (PMID: 26839366)
171 MIR23B Diabetic Nephropathy Human cell line Human kidney proximal tubular epithelial cell (HK2) LIU, Haifeng, et al. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy. The international journal of biochemistry & cell biology, 2016, 70: 149-160. (PMID: 26646104)
172 MIR23B Diabetic Nephropathy Human patient Peripheral blood ZHAO, Binghai, et al. MicroRNA-23b targets ras GTPase-activating protein SH3 domain-binding protein 2 to alleviate fibrosis and albuminuria in diabetic nephropathy. Journal of the American Society of Nephrology, 2016, ASN. 2015030300. (PMID: 26839366)
173 MIR25 Diabetic Nephropathy Biopsied tissue Kidney tissue LI, Huicong, et al. MicroRNA-25 inhibits high glucose-induced apoptosis in renal tubular epithelial cells via PTEN/AKT pathway. Biomedicine & Pharmacotherapy, 2017, 96: 471-479. (PMID: 29031207)
174 MIR25 Diabetic Nephropathy Human patient Plasma BIJKERK, R., et al. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation. American Journal of Transplantation, 2015, 15.4: 1081-1090. (PMID: 25716422)
175 MIR25 Diabetic Nephropathy Human patient Serum LI, Huicong, et al. MicroRNA-25 inhibits high glucose-induced apoptosis in renal tubular epithelial cells via PTEN/AKT pathway. Biomedicine & Pharmacotherapy, 2017, 96: 471-479. (PMID: 29031207)
176 MIR25 Diabetic Retinopathy Human patient Serum LIU, Yunshuang, et al. Variations in MicroRNA-25 expression influence the severity of diabetic kidney disease. Journal of the American Society of Nephrology, 2017, 28.12: 3627-3638. (PMID: 28923913)
177 MIR25 Diabetic Retinopathy Human patient Serum LIU, Yunshuang, et al. Variations in MicroRNA-25 expression influence the severity of diabetic kidney disease. Journal of the American Society of Nephrology, 2017, 28.12: 3627-3638. (PMID: 28923913)
178 MIR25 Diabetic Retinopathy Human patient Serum LIU, Yunshuang, et al. Variations in MicroRNA-25 expression influence the severity of diabetic kidney disease. Journal of the American Society of Nephrology, 2017, 28.12: 3627-3638. (PMID: 28923913)
179 MIR26A1 Hyperglycemia Human cell line Umbilical vein endothelial cell (UVEC) SILAMBARASAN, Maskomani, et al. MicroRNAs in hyperglycemia induced endothelial cell dysfunction. International journal of molecular sciences, 2016, 17.4: 518. (PMID: 27070575)
180 MIR26A1 Diabetic Nephropathy Mouse Renal glomerular capsule KOGA, K., et al. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy. Diabetologia, 2015, 58.9: 2169-80 (PMID: 26063197)
181 MIR26A1 Diabetic Nephropathy Biopsied tissue Podocytes KOGA, K., et al. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy. Diabetologia, 2015, 58.9: 2169-80 (PMID: 26063197)
182 MIR26B Hyperglycemia Human cell line Umbilical vein endothelial cell (UVEC) SILAMBARASAN, Maskomani, et al. MicroRNAs in hyperglycemia induced endothelial cell dysfunction. International journal of molecular sciences, 2016, 17.4: 518. (PMID: 27070575)
183 MIR26B Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
184 MIR27A Diabetic Nephropathy Human patient Plasma BIJKERK, R., et al. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation. American Journal of Transplantation, 2015, 15.4: 1081-1090. (PMID: 25716422)
185 MIR27A Diabetic Nephropathy Human patient Serum ZHOU, Zhanmei, et al. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy. Cell death & disease, 2017, 8.3: e2658. (PMID: 28277542)
186 MIR27B Diabetic Retinopathy Human patient Serum ZAMPETAKI, Anna, et al. Angiogenic microRNAs linked to incidence and progression of diabetic retinopathy in type 1 diabetes. Diabetes, 2015, db150389. (PMID: 26395742)
187 MIR2861 Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
188 MIR2861 Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
189 MIR2861 Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
190 MIR29A Diabetic Retinopathy Human patient Vitreous humor HIROTA, Kazunari, et al. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2015, 253.3: 335-342. (PMID: 24970617)
191 MIR29A Microvascular complications Human patient Urine PENG, Hui, et al. Urinary miR-29 correlates with albuminuria and carotid intima-media thickness in type 2 diabetes patients. PloS one, 2013, 8.12: e82607. (PMID: 24349318)
192 MIR29A Diabetic Retinopathy Human patient Blood HIROTA, Kazunari, et al. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2015, 253.3: 335-342. (PMID: 24970617)
193 MIR29A End-stage renal disease Human patient Plasma PEZZOLESI, Marcus G., et al. Circulating TGF-β1–regulated miRNAs and the risk of rapid progression to ESRD in type 1 diabetes. Diabetes, 2015, 64.9: 3285-3293. (PMID: 25931475)
194 MIR29A End-stage renal disease Human patient Serum ASSMANN, Taís S., et al. Circulating miRNAs in diabetic kidney disease: case–control study and in silico analyses. Acta diabetologica, 2019, 56.1: 55-65. (PMID: 30167868)
195 MIR29A Diabetic Nephropathy Human patient Serum CHIEN, Hung-Yu, et al. Differential microRNA profiles predict diabetic nephropathy progression in Taiwan. International journal of medical sciences, 2016, 13.6: 457. (PMID: 27279796)
196 MIR29B1 Hyperglycemia Human cell line Umbilical vein endothelial cell (UVEC) SILAMBARASAN, Maskomani, et al. MicroRNAs in hyperglycemia induced endothelial cell dysfunction. International journal of molecular sciences, 2016, 17.4: 518. (PMID: 27070575)
197 MIR29B1 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
198 MIR29C Hyperglycemia Human cell line Umbilical vein endothelial cell (UVEC) SILAMBARASAN, Maskomani, et al. MicroRNAs in hyperglycemia induced endothelial cell dysfunction. International journal of molecular sciences, 2016, 17.4: 518. (PMID: 27070575)
199 MIR29C Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
200 MIR29C Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
201 MIR30A Microalbuminuria Human patient Urine ARGYROPOULOS, Christos, et al. Urinary MicroRNA profiling predicts the development of microalbuminuria in patients with Type 1 diabetes. Journal of clinical medicine, 2015, 4.7: 1498-1517. (PMID: 26239688)
202 MIR30A Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
203 MIR30B Diabetic Retinopathy Human patient Tissue, cell types, and enzyme sources MAZZEO, Aurora, et al. Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects. Experimental eye research, 2018, 176: 69-77. (PMID: 30008390)
204 MIR30B Diabetic Retinopathy Human patient Tissue, cell types, and enzyme sources MAZZEO, Aurora, et al. Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects. Experimental eye research, 2018, 176: 69-77. (PMID: 30008390)
205 MIR30D Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
206 MIR30D Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
207 MIR30E Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
208 MIR30E Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
209 MIR31 Diabetic Nephropathy Human patient Serum ROVIRA-LLOPIS, Susana, et al. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation. Cellular Physiology and Biochemistry, 2018, 50.3: 1005-1014. (PMID: 30355913)
210 MIR31 Diabetic Nephropathy Human patient Serum ROVIRA-LLOPIS, Susana, et al. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation. Cellular Physiology and Biochemistry, 2018, 50.3: 1005-1014. (PMID: 30355913)
211 MIR31 Diabetic Nephropathy Human patient Serum ROVIRA-LLOPIS, Susana, et al. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation. Cellular Physiology and Biochemistry, 2018, 50.3: 1005-1014. (PMID: 30355913)
212 MIR31 Diabetic Nephropathy Human patient Serum ROVIRA-LLOPIS, Susana, et al. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation. Cellular Physiology and Biochemistry, 2018, 50.3: 1005-1014. (PMID: 30355913)
213 MIR3191 End-stage renal disease Human patient Animal XIE, Yijun, et al. Urinary exosomal microRNA profiling in incipient type 2 diabetic kidney disease. Journal of diabetes research, 2017, 2017. (PMID: 29038788)
214 MIR320A Hyperglycemia Human cell line Umbilical vein endothelial cell (UVEC) SILAMBARASAN, Maskomani, et al. MicroRNAs in hyperglycemia induced endothelial cell dysfunction. International journal of molecular sciences, 2016, 17.4: 518. (PMID: 27070575)
215 MIR320A Diabetic Retinopathy Human patient Vitreous humor HIROTA, Kazunari, et al. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2015, 253.3: 335-342. (PMID: 24970617)
216 MIR320A Diabetic Retinopathy Human patient Blood HIROTA, Kazunari, et al. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2015, 253.3: 335-342. (PMID: 24970617)
217 MIR320A Diabetic Nephropathy Human patient Plasma BIJKERK, R., et al. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation. American Journal of Transplantation, 2015, 15.4: 1081-1090. (PMID: 25716422)
218 MIR320A Diabetic Retinopathy Human patient Serum ZAMPETAKI, Anna, et al. Angiogenic microRNAs linked to incidence and progression of diabetic retinopathy in type 1 diabetes. Diabetes, 2015, db150389. (PMID: 26395742)
219 MIR320A Impaired Angiogenesis Rat Myocardial microvascular endothelial cells (MMVECs) WANG, X. H., et al. MicroRNA‐320 expression in myocardial microvascular endothelial cells and its relationship with insulin‐like growth factor‐1 in type 2 diabetic rats. Clinical and Experimental Pharmacology and Physiology, 2009, 36.2: 181-188. (PMID: 18986336)
220 MIR320B1 Diabetic Retinopathy Human patient Vitreous humor HIROTA, Kazunari, et al. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2015, 253.3: 335-342. (PMID: 24970617)
221 MIR320B1 Diabetic Retinopathy Human patient Blood HIROTA, Kazunari, et al. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2015, 253.3: 335-342. (PMID: 24970617)
222 MIR320C1 Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
223 MIR323B Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
224 MIR324 End-stage renal disease Human patient Animal XIE, Yijun, et al. Urinary exosomal microRNA profiling in incipient type 2 diabetic kidney disease. Journal of diabetes research, 2017, 2017. (PMID: 29038788)
225 MIR325 Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
226 MIR326 Diabetic Nephropathy Human patient Plasma BIJKERK, R., et al. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation. American Journal of Transplantation, 2015, 15.4: 1081-1090. (PMID: 25716422)
227 MIR335 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
228 MIR338 Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
229 MIR340 Diabetic Nephropathy Human patient Plasma BIJKERK, R., et al. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation. American Journal of Transplantation, 2015, 15.4: 1081-1090. (PMID: 25716422)
230 MIR34A Impaired Angiogenesis Mouse Microvascular endothelial cell (MVEC) ARUNACHALAM, Gnanapragasam, et al. Molecular interplay between microRNA-34a and Sirtuin1 in hyperglycemia-mediated impaired angiogenesis in endothelial cells: effects of metformin. Journal of Pharmacology and Experimental Therapeutics, 2016, 356.2: 314-323. (PMID: 26582729)
231 MIR362 End-stage renal disease Human patient Animal XIE, Yijun, et al. Urinary exosomal microRNA profiling in incipient type 2 diabetic kidney disease. Journal of diabetes research, 2017, 2017. (PMID: 29038788)
232 MIR363 Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
233 MIR371B Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
234 MIR373 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
235 MIR375 Diabetic Retinopathy Human patient Vitreous humor HIROTA, Kazunari, et al. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2015, 253.3: 335-342. (PMID: 24970617)
236 MIR375 Type 2 Diabetes Mellitus Mouse Serum HIGUCHI, Chigusa, et al. Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes. Metabolism, 2015, 64.4: 489-497. (PMID: 25726255)
237 MIR377 Diabetic Nephropathy Mouse Renal glomerular capsule WANG, Qiang, et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. The FASEB Journal, 2008, 22.12: 4126-4135. (PMID: 18716028)
238 MIR377 Diabetic Nephropathy Human cell line Mesangial cell WANG, Qiang, et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. The FASEB Journal, 2008, 22.12: 4126-4135. (PMID: 18716028)
239 MIR377 End-stage renal disease Human patient Urine EL-SAMAHY, Mona Hussein, et al. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes. Journal of Diabetes and its Complications, 2018, 32.2: 185-192. (PMID: 29175120)
240 MIR377 End-stage renal disease Human patient Urine EL-SAMAHY, Mona Hussein, et al. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes. Journal of Diabetes and its Complications, 2018, 32.2: 185-192. (PMID: 29175120)
241 MIR377 End-stage renal disease Human patient Blood AL‑KAFAJI, Ghada; AL‑MUHTARESH, Haifa Abdulla. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. Molecular medicine reports, 2018, 18.1: 1171-1180. (PMID: 29845236)
242 MIR377 End-stage renal disease Human patient Blood AL‑KAFAJI, Ghada; AL‑MUHTARESH, Haifa Abdulla. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. Molecular medicine reports, 2018, 18.1: 1171-1180. (PMID: 29845236)
243 MIR377 End-stage renal disease Human patient Blood AL‑KAFAJI, Ghada; AL‑MUHTARESH, Haifa Abdulla. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. Molecular medicine reports, 2018, 18.1: 1171-1180. (PMID: 29845236)
244 MIR377 End-stage renal disease Human patient Blood AL‑KAFAJI, Ghada; AL‑MUHTARESH, Haifa Abdulla. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. Molecular medicine reports, 2018, 18.1: 1171-1180. (PMID: 29845236)
245 MIR377 End-stage renal disease Human patient Blood AL‑KAFAJI, Ghada; AL‑MUHTARESH, Haifa Abdulla. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. Molecular medicine reports, 2018, 18.1: 1171-1180. (PMID: 29845236)
246 MIR378A End-stage renal disease Human patient Serum ASSMANN, Taís S., et al. Circulating miRNAs in diabetic kidney disease: case–control study and in silico analyses. Acta diabetologica, 2019, 56.1: 55-65. (PMID: 30167868)
247 MIR423 Diabetic Nephropathy Biopsied tissue Renal tissue XU, Yuxiang, et al. miR-423-5p suppresses high-glucose-induced podocyte injury by targeting Nox4. Biochemical and biophysical research communications, 2018, 505.2: 339-345. (PMID: 30245133)
248 MIR423 Diabetic Retinopathy Human patient Blood HIROTA, Kazunari, et al. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2015, 253.3: 335-342. (PMID: 24970617)
249 MIR424 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
250 MIR424 Diabetic Nephropathy Human patient Urine BARUTTA, Federica, et al. Urinary exosomal microRNAs in incipient diabetic nephropathy. PloS one, 2013, 8.11: e73798. (PMID: 24223694)
251 MIR4270 Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
252 MIR429 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
253 MIR451A Diabetic Nephropathy Rat Urine MOHAN, Aradhana, et al. Urinary exosomal microRNA-451-5p is a potential early biomarker of diabetic nephropathy in rats. PloS one, 2016, 11.4: e0154055. (PMID: 27101382)
254 MIR4532 Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
255 MIR4532 Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
256 MIR4536-1 Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
257 MIR4739 Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
258 MIR4778 Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
259 MIR485 Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
260 MIR486-1 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
261 MIR486-1 End-stage renal disease Human patient Serum REGMI, Anita, et al. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis. Medical science monitor: international medical journal of experimental and clinical research, 2019, 25: 1699. (PMID: 30835718)
262 MIR486-1 End-stage renal disease Human patient Serum REGMI, Anita, et al. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis. Medical science monitor: international medical journal of experimental and clinical research, 2019, 25: 1699. (PMID: 30835718)
263 MIR486-1 End-stage renal disease Human patient Serum REGMI, Anita, et al. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis. Medical science monitor: international medical journal of experimental and clinical research, 2019, 25: 1699. (PMID: 30835718)
264 MIR491 End-stage renal disease Human patient Animal XIE, Yijun, et al. Urinary exosomal microRNA profiling in incipient type 2 diabetic kidney disease. Journal of diabetes research, 2017, 2017. (PMID: 29038788)
265 MIR495 Microalbuminuria Human patient Urine ARGYROPOULOS, Christos, et al. Urinary MicroRNA profiling predicts the development of microalbuminuria in patients with Type 1 diabetes. Journal of clinical medicine, 2015, 4.7: 1498-1517. (PMID: 26239688)
266 MIR497 Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
267 MIR524 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
268 MIR548O Microalbuminuria Human patient Urine ARGYROPOULOS, Christos, et al. Urinary MicroRNA profiling predicts the development of microalbuminuria in patients with Type 1 diabetes. Journal of clinical medicine, 2015, 4.7: 1498-1517. (PMID: 26239688)
269 MIR552 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
270 MIR571 Microvascular complications Human patient Serum WANG, Cheng, et al. Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus. Scientific reports, 2016, 6. (PMID: 26831044)
271 MIR572 Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
272 MIR574 Diabetic Nephropathy Human patient Plasma BIJKERK, R., et al. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation. American Journal of Transplantation, 2015, 15.4: 1081-1090. (PMID: 25716422)
273 MIR589 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
274 MIR592 Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
275 MIR6068 Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
276 MIR6126 Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
277 MIR6133 Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
278 MIR619 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
279 MIR638 End-stage renal disease Human patient Animal XIE, Yijun, et al. Urinary exosomal microRNA profiling in incipient type 2 diabetic kidney disease. Journal of diabetes research, 2017, 2017. (PMID: 29038788)
280 MIR638 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
281 MIR638 Diabetic Nephropathy Human patient Urine DELIĆ, Denis, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PloS one, 2016, 11.3: e0150154. (PMID: 26930277)
282 MIR660 Diabetic Nephropathy Human patient Plasma BIJKERK, R., et al. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas–kidney transplantation. American Journal of Transplantation, 2015, 15.4: 1081-1090. (PMID: 25716422)
283 MIR661 Microvascular complications Human patient Serum WANG, Cheng, et al. Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus. Scientific reports, 2016, 6. (PMID: 26831044)
284 MIR6747 Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
285 MIR6839 Diabetic Nephropathy Human patient Urine CARDENAS-GONZALEZ, Mariana, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clinical chemistry, 2017, 63.9: 1515-1526. (PMID: 28667184)
286 MIR7-1 Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
287 MIR7-1 Microvascular complications Human patient Serum WAN, Shujun, et al. Increased serum miR-7 is a promising biomarker for type 2 diabetes mellitus and its microvascular complications. Diabetes research and clinical practice, 2017, 130: 171-179. (PMID: 28646700)
288 MIR7-1 Microvascular complications Human patient Serum WAN, Shujun, et al. Increased serum miR-7 is a promising biomarker for type 2 diabetes mellitus and its microvascular complications. Diabetes research and clinical practice, 2017, 130: 171-179. (PMID: 28646700)
289 MIR708 Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
290 MIR764 Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
291 MIR765 Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
292 MIR770 Microvascular complications Human patient Serum WANG, Cheng, et al. Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus. Scientific reports, 2016, 6. (PMID: 26831044)
293 MIR802 Type 2 Diabetes Mellitus Mouse Serum HIGUCHI, Chigusa, et al. Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes. Metabolism, 2015, 64.4: 489-497. (PMID: 25726255)
294 MIR877 End-stage renal disease Human patient Animal XIE, Yijun, et al. Urinary exosomal microRNA profiling in incipient type 2 diabetic kidney disease. Journal of diabetes research, 2017, 2017. (PMID: 29038788)
295 MIR892B Microvascular complications Human patient Serum WANG, Cheng, et al. Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus. Scientific reports, 2016, 6. (PMID: 26831044)
296 MIR9-1 Diabetic Nephropathy Human patient Serum XIAO, Yanxin, et al. Diabetic nephropathy: serum miR-9 confers a poor prognosis in and is associated with level changes of vascular endothelial growth factor and pigment epithelium-derived factor. Biotechnology letters, 2017, 39.10: 1583-1590. (PMID: 28667418)
297 MIR92A1 Diabetic Retinopathy Biopsied tissue CD34(+) cells BHATWADEKAR, Ashay D., et al. MiR-92a corrects CD34+ cell dysfunction in diabetes by modulating core circadian genes involved in progenitor differentiation. Diabetes, 2015, db150521. (PMID: 26283734)
298 MIR92B Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
299 MIR92B Diabetic Nephropathy Human patient Urine ARGYROPOULOS, Christos, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS one, 2013, 8.1: e54662. (PMID: 23358711)
300 MIR93 Diabetic Retinopathy Human patient Vitreous humor HIROTA, Kazunari, et al. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2015, 253.3: 335-342. (PMID: 24970617)
301 MIR93 Diabetic Retinopathy Biopsied tissue Kidney tissue MA, Jifang, et al. Up-regulation of microRNA-93 inhibits TGF-β1-induced EMT and renal fibrogenesis by down-regulation of Orai1. Journal of pharmacological sciences, 2018, 136.4: 218-227. (PMID: 29551286)
302 MIR93 Diabetic Retinopathy Human patient Blood HIROTA, Kazunari, et al. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2015, 253.3: 335-342. (PMID: 24970617)
303 MIR93 Diabetic Retinopathy Human patient Plasma ZOU, Hui-Ling, et al. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2017, 255.6: 1159-1166. (PMID: 28382439)
304 MIR93 Diabetic Retinopathy Human patient Plasma ZOU, Hui-Ling, et al. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy. Graefe`s Archive for Clinical and Experimental Ophthalmology, 2017, 255.6: 1159-1166. (PMID: 28382439)
305 MIR96 Diabetic Retinopathy Rat Retina WU, Jin-hui, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic research, 2012, 47.4: 195-201. (PMID: 22156553)
306 MIRLET7A1 Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
307 MIRLET7A1 Microalbuminuria Human patient Urine ARGYROPOULOS, Christos, et al. Urinary MicroRNA profiling predicts the development of microalbuminuria in patients with Type 1 diabetes. Journal of clinical medicine, 2015, 4.7: 1498-1517. (PMID: 26239688)
308 MIRLET7A3 Diabetic Nephropathy Human patient Plasma PENG, Rui, et al. Promoter hypermethylation of let-7a-3 is relevant to its down-expression in diabetic nephropathy by targeting UHRF1. Gene, 2015, 570.1: 57-63. (PMID: 26049093)
309 MIRLET7B End-stage renal disease Human patient Plasma PEZZOLESI, Marcus G., et al. Circulating TGF-β1–regulated miRNAs and the risk of rapid progression to ESRD in type 1 diabetes. Diabetes, 2015, 64.9: 3285-3293. (PMID: 25931475)
310 MIRLET7C End-stage renal disease Human patient Plasma PEZZOLESI, Marcus G., et al. Circulating TGF-β1–regulated miRNAs and the risk of rapid progression to ESRD in type 1 diabetes. Diabetes, 2015, 64.9: 3285-3293. (PMID: 25931475)
311 MIRLET7F1 Type 2 Diabetes Mellitus Rat Pancreatic islet ZENG, Ling‑Qin, et al. Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto‑Kakizaki rats. Molecular medicine reports, 2015, 11.1: 67-74. (PMID: 25333294)
312 MIRLET7I Diabetic Neuropathy Mouse Spinal ganglion CHENG, Chu, et al. Evidence for epigenetic regulation of gene expression and function in chronic experimental diabetic neuropathy. Journal of Neuropathology & Experimental Neurology, 2015, 74.8: 804-817. (PMID: 26172287)
miR2Diabetes: A manually curated microRNA database for diabetic microvascular complications